Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention Program
Author(s) -
Kieren J. Mather,
Tohru Funahashi,
Yūji Matsuzawa,
Sharon L. Edelstein,
George A. Bray,
Steven E. Kahn,
Jill P. Crandall,
Santica M. Marcovina,
Barry Goldstein,
Ronald Goldberg
Publication year - 2008
Publication title -
diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.219
H-Index - 330
eISSN - 1939-327X
pISSN - 0012-1797
DOI - 10.2337/db07-1419
Subject(s) - adiponectin , metformin , medicine , diabetes mellitus , placebo , hazard ratio , endocrinology , adipokine , insulin resistance , confidence interval , alternative medicine , pathology
To determine whether baseline adiponectin levels or intervention-associated change in adiponectin levels were independently associated with progression to diabetes in the Diabetes Prevention Program (DPP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom